Progressive substitution of posttransplant cyclophosphamide with bendamustine: A phase I study in haploidentical bone marrow transplantation

We have initiated a single center phase I study in patients with hematologic malignancies progressively substituting day +4 posttransplant cyclophosphamide (PT‐CY) with bendamustine (PT‐BEN) following myeloablative conditioning (MAC) and T‐cell replete haploidentical bone marrow transplantation (hap...

Descripción completa

Detalles Bibliográficos
Autores principales: Katsanis, Emmanuel, Maher, Keri, Roe, Denise J., Simpson, Richard J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176108/
https://www.ncbi.nlm.nih.gov/pubmed/35847727
http://dx.doi.org/10.1002/jha2.20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176108/
https://www.ncbi.nlm.nih.gov/pubmed/35847727
http://dx.doi.org/10.1002/jha2.20

Ejemplares similares